Texas Yale Capital Corp’s Elevance Health ELV Stock Holding History

Texas Yale Capital Corp’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,175	Closed	-$433K	–	457
2024 Q4	$433K	Buy	1,175 +105	+10%	+$43.9K	0.02%	344
2024 Q3	$556K	Buy	1,070 +20	+2%	+$10.7K	0.02%	325
2024 Q2	$569K	Hold	1,050	–	–	0.03%	309
2024 Q1	$544K	Hold	1,050	–	–	0.02%	314
2023 Q4	$495K	Hold	1,050	–	–	0.02%	319
2023 Q3	$457K	Hold	1,050	–	–	0.02%	311
2023 Q2	$467K	Sell	1,050 -1,997	-66%	-$921K	0.02%	324
2023 Q1	$1.4M	Buy	3,047 +950	+45%	+$452K	0.07%	202
2022 Q4	$1.08M	Hold	2,097	–	–	0.06%	233
2022 Q3	$953K	Hold	2,097	–	–	0.06%	237
2022 Q2	$1.01M	Hold	2,097	–	–	0.07%	228
2022 Q1	$1.03M	Hold	2,097	–	–	0.06%	238
2021 Q4	$972K	Hold	2,097	–	–	0.05%	247
2021 Q3	$782K	Buy	2,097 +100	+5%	+$38K	0.04%	267
2021 Q2	$762K	Hold	1,997	–	–	0.04%	269
2021 Q1	$717K	Hold	1,997	–	–	0.05%	271
2020 Q4	$641K	Hold	1,997	–	–	0.04%	284
2020 Q3	$536K	Hold	1,997	–	–	0.04%	290
2020 Q2	$525K	Hold	1,997	–	–	0.04%	283
2020 Q1	$453K	Hold	1,997	–	–	0.04%	283
2019 Q4	$603K	Hold	1,997	–	–	0.04%	303
2019 Q3	$479K	Hold	1,997	–	–	0.03%	331
2019 Q2	$564K	Sell	1,997 -1,997	-50%	-$546K	0.04%	312
2019 Q1	$1.15M	Buy	3,994 +1,997	+100%	+$578K	0.05%	301
2018 Q4	$524K	Hold	1,997	–	–	0.05%	293
2018 Q3	$547K	Hold	1,997	–	–	0.04%	313
2018 Q2	$475K	Hold	1,997	–	–	0.04%	325
2018 Q1	$439K	Hold	1,997	–	–	0.04%	338
2017 Q4	$449K	Hold	1,997	–	–	0.04%	334
2017 Q3	$379K	Hold	1,997	–	–	0.03%	351
2017 Q2	$376K	Hold	1,997	–	–	0.03%	349
2017 Q1	$330K	Hold	1,997	–	–	0.03%	363
2016 Q4	$287K	Hold	1,997	–	–	0.03%	376
2016 Q3	$250K	Hold	1,997	–	–	0.02%	406
2016 Q2	$262K	Hold	1,997	–	–	0.03%	397
2016 Q1	$278K	Hold	1,997	–	–	0.03%	377
2015 Q4	$278K	Hold	1,997	–	–	0.03%	380
2015 Q3	$280K	Hold	1,997	–	–	0.03%	396
2015 Q2	$328K	Hold	1,997	–	–	0.03%	402
2015 Q1	$308K	Hold	1,997	–	–	0.02%	410
2014 Q4	$251K	Sell	1,997 -618	-24%	-$76.4K	0.02%	418
2014 Q3	$313K	Buy	2,615 +618	+31%	+$70.9K	0.03%	360
2014 Q2	$215K	Buy	+1,997	New	+$206K	0.03%	349

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Texas Yale Capital Corp's ELV Position: Q1 2025 in Review

Texas Yale Capital Corp sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1,175 shares — an estimated $433K sold.

Texas Yale Capital Corp first reported a position in ELV in Q2 2014 and held it in 43 quarters. The position peaked at $1.4M in Q1 2023. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Texas Yale Capital Corp reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Texas Yale Capital Corp sold 1,175 Elevance Health shares in Q1 2025, an estimated $433K.
Texas Yale Capital Corp first reported a position in Elevance Health in Q2 2014 and held it in 43 quarters.
Texas Yale Capital Corp's Elevance Health position peaked at $1.4M in Q1 2023.
1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Texas Yale Capital Corp's 13F filing for Q1 2025, filed 7 May 2025.